NanoSanguis Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $789K
Latest Deal Amount
  • Investors
  • 4

NanoSanguis General Information


Developer of red blood cell substitute designed to offer an alternative to natural blood. The company's blood cell substitute uses a biotechnology method for producing synthetic oxygen carrier which is stable for at least one year of storage and is developing blood substitute based on full physiological, buffered fluid composed of balanced minerals compatible with human organism, enabling clinics to meet the rapidly increasing blood deficit.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Healthcare Services
Primary Office
  • Rakowiecka 36
  • Warsaw, 02-532
  • Poland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoSanguis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 16-Aug-2019 $789K Completed Generating Revenue
2. Early Stage VC 01-Jan-2015 Completed Startup
1. Grant Completed Startup
To view NanoSanguis’s complete valuation and funding history, request access »

NanoSanguis Executive Team (3)

Name Title Board Seat Contact Info
Agata Stefanek Ph.D Co-Founder, Chief Executive Officer & Researcher
Kamil Kopeć Ph.D Chief Operating Officer & Board Member
Tomasz Ciach Co-Founder & Member of Supervisory Board
To view NanoSanguis’s complete executive team members history, request access »

NanoSanguis Board Members (4)

Name Representing Role Since
Kamil Kopeć Ph.D Self Chief Operating Officer & Board Member 000 0000
Maciek Sadowski Startup Hub Poland Member of the Supervisory Board 000 0000
Marek Borzestowski Giza Polish Ventures President of the Supervisory Board 000 0000
Paweł Ciach Self Member of the Supervisory Board 000 0000
To view NanoSanguis’s complete board members history, request access »

NanoSanguis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NanoSanguis Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Regional Development Fund Other 000 0000 000000 0
Giza Polish Ventures Venture Capital Minority 000 0000 000000 0
StarFinder Venture Capital Minority 000 0000 000000 0
Startup Hub Poland Accelerator/Incubator Minority 000 0000 000000 0
To view NanoSanguis’s complete investors history, request access »